Keisuke Yoneda, Masaru Takeuchi, Tsutomu Yasukawa, Hiroto Terasaki, Yuki Yamamoto, Tatsuya Jujo, Makiko Wakuta, Hisashi Matsubara, Yoshinori Mitamura, Aki Kato, Mineo Kondo, Kazuhiro Kimura, Hitoshi Takagi, Fumi Gomi, Taiji Sakamoto
PURPOSE: Neovascular age-related macular degeneration (nAMD) is classified into typical AMD (tAMD), polypoidal choroidal vasculopathy (PCV), and retinal angiomatous proliferation (RAP). This study investigated clinical features of the three subtypes and visual outcome associated with real-world treatment regimens in a large cohort of nAMD patients. DESIGN: Retrospective multicenter cohort study PARTICIPANTS: Five hundred treatment-naïve nAMD (268 tAMD, 200 PCV, and 32 RAP) patients initiated with anti-VEGF agents and followed for 1 year...
June 7, 2023: Ophthalmology Retina